For many years, platinum-based chemotherapy has been one of the mainstays for advanced testicular cancer. Painful peripheral ...

The risk of developing dementia may be double what was previously thought. But there are things the U.S. can do to help fight ...

As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...

The evidence of gabapentin and dementia is mixed, with two studies looking at hundreds of thousands of people and coming to ...

Dementia, a progressive disorder that impacts memory and independence, affects millions globally. While many are aware of ...

Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...

Researchers at the University of Kentucky's Sanders-Brown Center on Aging are at the forefront of advancing dementia research ...

SHENZHEN, CHINA, Jan. 08, 2025 (GLOBE NEWSWIRE) -- China Medical System Holdings Limited (the “Company”, together with its subsidiaries, the “Group” or “CMS”) is pleased to announce ...

A new USC-led study suggests that assessing blood vessel health should be included in dementia diagnostics. A new USC-led ...

The FDA has accepted the BLA for lecanemab-irmb SC for weekly maintenance dosing in the treatment of early Alzheimer disease.

Use of the treatment has soared in popularity in recent years now taken by 2.6million women in England according to the ...

drugs to slow its progress and even a potential treatment to “gobble up” plaque-causing amyloid-beta in the brain.